Taysha Gene Therapies, Inc. (TSHA) Debt by Year
Taysha Gene Therapies, Inc. carried $50.1M in long-term debt against $319.8M in cash and equivalents at the end of fiscal year 2025. This represents an increase of 14.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Taysha Gene Therapies, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TSHA Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TSHA Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $49.3M+20.0% | $49.0M+15.3% | $50.1M+14.0% | $50.9M+18.3% | $41.1M+8.5% | $42.5M+4.8% | $43.9M+8.5% | $43.0M+11.5% | $37.8M-1.4% | $40.5M+6.2% | $40.5M+6.7% | $38.5M+2.1% |
| Cash & Equivalents | $455.4M+45.6% | $276.6M+137.2% | $319.8M+130.0% | $297.3M+88.6% | $312.8M+81.1% | $116.6M-6.0% | $139.0M-3.4% | $157.7M-4.0% | $172.7M+283.2% | $124.0M+95.5% | $143.9M+63.8% | $164.3M+378.9% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Taysha Gene Therapies, Inc. financials
Frequently Asked Questions
What was Taysha Gene Therapies, Inc.'s long-term debt in fiscal year 2025?
Taysha Gene Therapies, Inc. carried $50.1M in long-term debt against $319.8M in cash and equivalents at the end of fiscal year 2025.
How fast is Taysha Gene Therapies, Inc.'s long-term debt growing?
Taysha Gene Therapies, Inc. (TSHA) long-term debt rose by 14.0% year over year, from $43.9M to $50.1M in fiscal year 2025.
What was Taysha Gene Therapies, Inc.'s long-term debt in the most recent quarter?
Taysha Gene Therapies, Inc. (TSHA) reported $49.3M in long-term debt in Q2 2026. This represents an increase of 20.0% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Taysha Gene Therapies, Inc. (TSHA) reported on that line in every period on record.